Seed Investments

Building and investing in biotech from seed to success

What we do

We drive innovation in life sciences by identifying, building, and investing in transformative biotech startups. Leveraging the capabilities of our in-house SeedLab and our robust network of Entrepreneurs-in-Residence (EiRs), we focus on creating and nurturing companies to transform promising science into impactful therapeutic focused biotech companies.

For more insights and the stories behind our portfolio, visit our 'de novo' blog.

Our Approach

Building and Investing in New Companies

We partner with visionary scientists and entrepreneurs to build and invest in new companies, driving them from seed to success with our strategic support and resources.

Explore

In-house SeedLab

Our in-house SeedLab propels early-stage projects by validating experimental data and accelerating drug discovery, bridging the gap between theory and therapy.

Explore

Entrepreneurs-in-Residence (EiRs)

Our EiRs bring their operational excellence, industry insights, and strategic vision to the forefront, helping to steer projects from incubation to fruition.

Explore

“Through our hands-on approach, we ensure that promising projects and startup companies have the optimal conditions for success.”

Søren Møller,

Managing Partner, Seed Investments

Novo Holdings Quantum Investments

Quantum technology is rapidly gaining momentum, with the potential to transform industries from healthcare to sustainability. Building on Denmark’s strong research base and global partnerships, Novo Holdings is supporting start-ups and funds to ensure the Nordics play a leading role in shaping the future of quantum innovation.

Learn more about Novo Holdings Quantum Investments.

Strategy - From startup to exit

We provide capital, network and know-how to transform promising life-science discoveries into successful biotech startups.

We focus on company creation and building biotech startups in the Nordic region. Seed Investments aims to develop strong and competitive companies that we finance all the way to a commercial exit.

By the end of 2024, Seeds Investments’ portfolio comprised of 35 companies. Most of the portfolio consists of private investments, valued at DKK 4.2 billion at year end, 19% higher than at the end of 2023.